Germline Brca-mutated Breast Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-11-15
Clinical Trial Update: Neoadjuvant Fluzoparib Combined With Camrelizumab in Germline BRCA-mutated HER2-negative Breast Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant fluzoparib with camrelizumab in germline BRCA-mutated, HER2-negative breast cancer is currently enrolli…